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ABSTRACT 
 
 
Astrocytomas, with their different grades, occur in young adulthood. 
Malignant astrocytomas are characterized by uncontrolled proliferation and a high 
invasiness profile to adjacent normal regions of the brain. The invasion of 
astrocytomas to nearby sites is mediated by the formation of invadopodia which is 
regulated mainly by Rho GTPases. Cdc42, a member of the Rho GTPases family, 
was shown to be involved in such process in many cell lines.  
We aimed first in determining the involvement of Cdc42 in 2D astrocytoma motility. 
Our results showed that 2D cell migration is Cdc42 independent. Our current study 
also investigated the role of Cdc42 in invadopodia formation in MTLn3 breast cancer 
cells and SF268 astrocytoma cells. Our results showed that Cdc42 in required for the 
formation of these structures. And finally, we elucidated signaling pathways between 
Cdc42, other Rho GTPases and Palladin in SF268 cells. Our findings revealed that 
RhoA upregulates Cdc42 activation levels, whereas RhoC and Palladin downregulate 
them. 
Keywords: Astrocytoma, Rho GTPases, Cdc42, invadopodia, Palladin. 
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Chapter I 
?
Literature Review 
 
1.1. Brain Cancers 
1.1.1. Statistics and Epidemiology 
 According to the American Cancer Society, Cancer is the second most 
common cause of death in the US, exceeded by heart diseases and around 585,720 
Americans are estimated to die of cancer, almost 1,600 people per day in 2014. More 
specifically, approximately 2.4% of deaths cases are due to brain and other nervous 
system cancers. On the other hand, the estimated new cases of cancer are about 
1,665,540 where 23,380 are of brain and other nervous system cancers accounting 
for 1.4% of the total estimated new cases (American Cancer Society, 2014). Table1 
shows the estimated incidence and mortality rates from brain and other nervous 
systems (per 100,000) compared to all sites cancers by level of economic 
development and sex. In men, the incidence rate for all cancers combined was higher 
in more developed countries compared to less developed countries (300.1 vs. 160.3, 
respectively). In women, the same rates were obtained (225.5 vs. 138.0). In contrast, 
the mortality rate for all cancers combined was generally similar between more 
developed and less developed countries, particularly among women (87.3 vs. 85.4, 
respectively).  
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1.1.2. Brain tumors classification    
The classification of primary brain tumors by the World Health Organization 
(WHO) is based on their cellular origin and their histological features. They are 
classified into five classes including, tumors of the cranial and paraspinal nerves, 
neuroepithelial tumors, tumors of the meninges, lymphomas and hematopoietic 
neoplasms, and a fifth class which includes Germ cell tumors and tumors of the sellar 
region (Louis, Ohgaki, Wiestler, & Cavenee, 2007).  
The second most frequently reported histology and the most common 
malignancy are glioblastomas, accounting for 15.6% of all primary brain tumors and 
45.2% of primary malignant brain tumors. They are more common mostly in older 
adults. Glioblastomas comprise approximately 3% of all brain and CNS tumors 
Table 1. Estimated Incidence and Mortality Rates from Brain and other nervous system 
cancers (per 100,000) compared to all sites cancers by Sex, and Level of Economic 
Development, 2008. 
Source: GLOBOCAN 2008. 
                                     Males                                         Females 
Developed Countries Developing Countries Developed Countries Developing Countries 
  Incidence         Mortality   Incidence Mortality   Incidence Mortality   Incidence Mortality 
    6.0     3.9     3.2      2.6      4.4      2.6       2.8     2.0 
* 300.1  *143.9 * 160.3   *119.3 * 225.5    *87.3  * 138.0     *85.4 
*All sites (excluding nonmelanoma skin cancer) 
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reported among newborns up to 19 year olds.  The incidence of glioblastoma 
increases with age; 75 to 84 years olds comprise the highest rates.  Glioblastomas’ 
occurrence is 1.57 times more common in males and two to three times higher 
among whites as compared to blacks. The relative survival estimates for 
glioblastoma are quite low; less than 5% of patients survived five years post 
diagnosis (Louis, et al., 2007).  
 
1.2. Astrocytomas 
Gliomas that arise from normal astrocytes are called Astrocytomas. The WHO 
designates them under four different prognosis grades: grade I for non-invasive 
pilocytic astrocytoma, grade II for diffuse astrocytoma, grade III for malignant 
anaplastic astrocytoma and grade IV for glioblastoma multiforme (Tatter, Wislon, & 
Harsh, 1996). Despite intensive treatment, poor prognosis is usually linked to 
malignant astrocytomas accompanied with high mortality and morbidity rates. 
Patients suffering from anaplastic astrocytomas have a median survival time of 2 to 5 
years whereas patients with glioblastoma are estimated to live from 12 to 14 months 
(Wen & Kesari, 2008). These malignant forms of tumors metastasize into adjacent 
normal brain tissues but the reasons responsible for such process remain unclear. 
This renders them incontrollable surgically and/or medically and explains their high 
recurrence rate (Figure 1) (Nakada, Nakada, Demuth, Tran, Hoelzinger, & Berens, 
2007). 
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1.3. Cell Migration 
  
Cell migration constitutes an important cellular process involved in many 
physiological events including, embryogenesis, inflammation, tissue regeneration 
and wound healing. It has also an important role in cancer cell invasion and 
metastasis. Chemotaxis is a process based on cellular migration where the cell moves 
in response to a chemoattractant or a growth factor (Lauffenburger & Horwitz, 
1996).  
1.3.1. 2D cell motility 
 Upon the detection of a signal, a cell enters the cell motility cycle in its 
amoeboid-like form. This cycle starts with determining the direction of movement 
towards the chemoattractant by the cell, and then extension of actin rich protrusions 
(Bailly, Condeelis, & Segall, 1998). These protrusions are later on stabilized by the 
formation of adhesive structures to the cell substrate. This will anchor the cell and 
Figure 1. Local recurrence of malignant gliomas. A right parietal anaplastic 
astrocytoma (left) was operated, and a postoperative magnetic resonance imaging 
(MRI) scan confirmed complete removal (middle). Sixty-Gy radiation therapy was 
administered. Twelve months later, a routine MRI showed a recurrent tumor 
immediately adjacent to the resection cavity (right, yellow circle). 
(Source: Giese, Bjerkvig, Berens, & Westphal, 2003) 
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provide an anterograde mechanical force used to pull the cell body towards the 
chemoattractant. Simultaneously, the adhesion structures at the cell rear end are 
disassembled and the cell retracts its tail and move forward as depicted in figure 2 
(Bailly, Yan, Whitesides, Condeelis, & Segall, 1998; Condeelis, et al., 2001).   
   
  
 
  
Figure 2. The cell crawling cycle. The cycle is defined by three main steps: 1) the 
cell protrudes an extension in the direction of movement, 2) formation of new 
adhesion structures along with a detachment of these structures at the rear end, 3) cell 
body translocation. Top view of the motility cycle. 
(Source: Dylan Burnette, not published. Retrieved from 
https://science.nichd.nih.gov/confluence/display/sob/Cell+Motility) 
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1.3.2. 3D cell motility 
 Cancer cells metastasis is defined by their migration from the growing site of 
the tumor into the bloodstream by intravasation. They are carried to distal body parts 
where they extravasate out of the blood vessels and form secondary neoplastic 
tissues (Gertler, & Condeelis, 2011). In order for invasion to take place, cancer cells 
must detach from their nascent site, penetrate the extracellular matrix (ECM) by 
degrading the basement membrane by secreting matrix proteinases and migrate to 
blood and lymphatic vessels (Figure 3) (Gertler, & Condeelis, 2011; Sahai, 2005; 
Giese, et al., 2003).  
  
 
Figure 3. Cancer cell metastatic dissemination: how cancer cells cross endothelial 
barriers. It all starts with the detachment from the primary tumour site and 
intravasation into the neovasculature or nearby blood vessels after ECM invasion. 
Cancer cells travel through the blood circulation then extravasate at metastatic sites. 
(Source: Reymond, d'Água, & Ridley,  2013). 
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1.3.2.1. EMT 
 Epithelial-mesenchymal transition (EMT) constitutes a very important event 
in tumor progression and spread of primary cancerous cells to secondary metastatic 
sites (Thierry, 2002). A series of events must occur in order for the EMT of cancer to 
proceed. Downregulation of epithelial markers and an upregulation of mesenchymal 
proteins are key-events in this transition. An increase in motility, a loss of cell-cell 
adhesion, a pseudopodia formation, and elongated polarized shapes are the portrayed 
morphological changes of this event (Morra & Moch, 2011; Thierry, 2002). 
Weakening the immune system and evading safeguard mechanisms are assured by 
EMT through the progression and stability of metastasized tumors. This is 
accomplished by overcoming apoptotic pathways and premature senescence (Nieto, 
2011). However, in order for secondary site tumors to stabilize and colonize, they 
must revert back to their epithelial nature, a process known as MET (Nieto, 2011; 
Thierry, 2002). 
 
1.4. Invasive structures  
 Essential invasive structures or invadopodia are important in the invasion 
cycle. These are actin rich structures coupled with actin binding proteins, MMPs and 
actin remodeling proteins (Yamaguchi, Lorenz, Kempiak, Sarmiento, Coniglio, 
Symons, ... & Condeelis, 2005).  These structures extend vertically into the beneath 
ECM (Condeelis & Segall, 2003). Like in the case of 2D motility where plasma 
membrane protrusion structures are formed and called lamellipodia, signaling 
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proteins regulate the formation of invadopodia such as Arp2/3, cofilin, cortactin and 
N-WASP. MMPs are only present at the invadopodia level where the ECM 
degradation will take place. (Artym, Zhang, Seillier-Moiseiwitsch,Yamada, & 
Mueller, 2006; Weaver, 2006; Yamaguchi, et al., 2005). Each protein has its own 
function. Cofilin is responsible mainly for generating free barbed ends through 
severing actin filaments and leading to actin nucleation. Severing constitutes an 
important step since most actin filaments are capped in resting cells (Bravo-Cordero, 
et al., 2011; W. Wang, Eddy, & Condeelis, 2007). De novo nucleation of actin 
filaments, which will generate barbed ends, is mediated by the Arp2/3 complex, the 
future template for actin nucleation (Olson & Sahai, 2009). This complex is activated 
by the Wiskott - Aldrich syndrome protein (WASP) family. The VCA domain of 
Arp2/3 is a binding site of the WASP/SCAR/WAVE family of scaffold proteins, 
which play a role in actin polymerization (Olson & Sahai, 2009; Yamaguchi, et al., 
2005).  
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Figure 4. The stages of invadopodium formation. a) During initiation of 
invadopodium formation, cells establish focal adhesions with the extracellular matrix 
(ECM) through the interaction of integrins, SRC and Tyr397-phosphorylated focal 
adhesion kinase (FAK). b) The formation of invadopodia occurs through the 
recruitment and activation of ARP2/3 and WASP-interacting protein (WIP), the 
phosphorylation of key invadopodium components, such as cortactin. Cortactin 
associates with N-WASP and the ARP2/3 complex (the cortactin–ARP2/3 interaction 
is not shown here), and will generate a complex of WIP and dynamin during 
invadopodia formation. c) During maturation, invadopodia promote the degradation 
of the ECM by coordinating the secretion of matrix metalloprotease 2 (MMP2) and 
MMP9. 
(Source: Murphy, & Courtneidge, 2011) 
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1.5. Rho GTPases 
1.5.1. Hallmarks 
 Rho GTPases are members of the Rho (Ras-homologous) -family GTPases. 
They range between 20-40 KDa in size. They play a fundamental role in cancer cell 
motility and invasion including cytoskeletal re-organization, cellular polarity and 
signal transduction pathways through an interaction between each other (Sahai & 
Marshall, 2002; Tang, Olufemi, Wang, & Nie, 2008). This family comprises 
different members depicted in Figure 5 (Vega & Ridley, 2008). The three most 
studied Rho GTPases are Rho, Rac and Cdc42. They have distinct functions than 
other members of their family (Takai, Sasaki, & Matozaki, 2001; Vega & Ridley, 
2008). 
  
Figure 5. Phylogenic tree showing the mammalian Ras - GTPase 
superfamily. The 20 Rho GTPase family members are grouped into eight 
subfamilies. 
(Source: Vega & Ridley, 2008) 
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1.5.2. Rho GTPases as binary switches 
 Rho GTPases are molecular switches that mediate the invasiveness ability 
through actin and cytoskeleton organization (Keely et al., 1997). These 
molecules undergo cycles of activation under their GTP-bound form and 
deactivation under their GDP-bound form through GEFs (Guanine nucleotide 
Exchange Factor) and GAPs (GTPase activating protein), respectively. GDP 
dissociation inhibitors (GDIs) control the interaction of Rho GTPases with GEFs 
and GAPs by translocating them away from the plasma membrane (Figure 6) 
(Jaffe & Hall, 2005).   
 
 
 
 
  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 6. The GTPases cyle. Rho GTPases cycle between an active GTP-bound form by the 
action of GEFs and an inactive GDP-bound form by the action of GAPs. The GTP-bound 
active form interacts with downstream effectors and mediate a cellular response. 
(Source: Jaffe & Hall, 2005) 
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1.5.3. Cdc42 and Rac1 
 
 Cdc42, under its active form, causes extensive formation of filopodium, 
finger – like actin rich protrusion. In contrast, massive F-actin bundle (stress fiber) 
formation is mediated by active RhoA (Ridley, et al., 2003; Iden & Collard, 2008). 
Cdc42 and Rac1 are generally proposed to function at the leading edge to induce cell 
polarization and lamellipodium formation, respectively, whereas RhoA is believed to 
mainly act at the cell body to facilitate contraction (Yan, Shen, & Zhu, 2010). 
Scaffold proteins belonging to the WASP/SCAR/WAVE family containing 
the VCA domain are downstream signaling of Cdc42 and Rac1 (Keely, et al., 1997; 
Tang, et al., 2008). These regulate the Arp2/3 complex, the actin nucleation protein 
that stimulates actin polymerization at the leading edge of the cell (Figure 7) (Jaffe & 
Hall, 2005; Jiang, et al., 2009; Tang, et al., 2008; Yamaguchi, et al., 2005). 
The serine/threonine p21 activating kinase (PAK) is a common target protein 
of Rac1 and Cdc42 (Manser, Leung, Salihuddin, Zhao, & Lim, 1994). All PAK 
proteins share a common domain referred to as Cdc42/Rac interactive binding 
(CRIB) domain (Burbelo, Drechsel, & Hall, 1995; Manser, et al., 1994).  
In addition to its role in filopodia formation, Cdc42 was shown to be involved 
in PMA-induced invadopodia assembly in human melanoma cells, metastatic rat 
carcinoma mammary cells and smooth muscle cells (Goicoechea, Arneman, & Otey, 
2008). 
 
 13 
  
Figure 7. Rho GTPases and downstream effectors. Downstream targets of Rho 
include the serine/threonine kinase ROCK which is mainly involved in the 
formation of stress fibers and focal adhesions. Downstream signaling of Cdc42 and 
Rac includes scaffold proteins belonging to the WASP/SCAR/WAVE family, key 
regulators of actin nucleation and polymerization. p21 activating kinase (PAK) is a 
common effector protein of both Rac and Cdc42. 
(Source: Hanna, & El-Sibai, 2013) 
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1.6. Palladin 
 A recently discovered protein, palladin, co-localizes with actin-rich structures 
in a variety of cell types (Mykkanen et al., 2001; Parast, & Otey, 2000). 
Accumulating evidence, obtained from both microarray analysis of gene expression 
and cultured cell studies prove that palladin plays a key role in invasion (Goicoechea, 
et al., 2008). Figure 8 represents a functional model of the role of Palladin in 
multiple processes required for cell migration across tissue boundaries (Goicoechea, 
et al., 2008).  
 Goicoechea, et al. (2013) showed that Palladin is not only involved in cell 
adhesion and motility, but also in invasive motility of cancer invasive cells more 
specifically in CAFs (Cancer associated fibroblasts) (Goicoechea, García-Mata, 
Staub, Valdivia, Sharek, McCulloch, ... & Otey, 2013).  
 
1.7. Purpose of this study 
 The aim of this study is to elucidate the relationship between Cdc42 and 
Palladin in invadopodia formation in astrocytoma cancer cells through a) studying 
the effect of Cdc42 depletion on cellular motility, b) assessing the effect of the 
depletion of Cdc42 on invadopodia formation with a comparison to another cell line 
(Breast cancer cells), and c) examining the relationship between Palladin and Cdc42 
as well as between Cdc42, RhoA and RhoC. 
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Figure 8. A working model for the role of palladin in multiple processes 
required for cell migration across tissue boundaries. 
(Source: Goicoechea, et al., 2008) 
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Chapter II 
?
Materials & Methods 
 
2.1. Cell Culture 
 
Human astrocytoma cell lines SF268 and MTLn3 breast cancer cell lines were 
cultured in DMEM medium supplemented with 10% FBS and 100U 
penicillin/streptomycin at 37°C and 5% CO2 in a humidified chamber. 
 
 
2.2. Antibodies and reagents 
 
Rabbit polyclonal anti-RhoG, rabbit polyclonal anti-WASP, and mouse 
polyclonal anti-actin antibodies were obtained from Santa Cruz Biotechnology.  
Rabbit polyclonal anti-Cdc42, rabbit polyclonal anti-RhoA, rabbit polyclonal anti-
RhoC and Goat polyclonal anti-Palladin antibodies were purchased from Abcam. 
Anti-rabbit and anti-mouse HRP-conjugated secondary antibodies were obtained 
from Promega. Fluorescent secondary antibodies (AlexaFluor 488) were obtained 
from Invitrogen. To visualize the actin cytoskeleton, cells were stained with 
Rhodamine phalloidin (Invitrogen).  
 
2.3. PMA-mediated invadopodia induction 
Invadopodia induction in SF268 cells was performed using PMA (Sigma 
Aldrich) at a final concentration of 370 mM in L15 medium (0.35% BSA) with an 
incubation for 1 hour at 37°C and 5% CO2. Control phenotypes were incubated with 
DMSO instead of PMA since DMSO is the carrier solvent. 
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2.4. Cell transfection with siRNA 
 
Goat FlexiTube siRNA for Cdc42 (oligo 4  and 7), Palladin, RhoA and RhoC 
were obtained from Qiagen.  
The cells were transfected with the siRNA at a final concentration of 10 nM using 
HiPerfect (Qiagen) as described by the manufacturer. Control cells were transfected 
with siRNA sequences targeting GL2 Luciferase (Qiagen). After 72 hours, protein 
levels in total cell lysates were analyzed by western blotting using the appropriate 
antibodies or the effect of the corresponding knockdown was assayed. 
 
2.5. Western blotting 
 
Cell lysates (100µl) were prepared by scraping the cells in a sample buffer 
consisted of 4% SDS, 10% β-mercaptoethanol, 20% glycerol, 0.004% bromophenol 
blue, and 0.125 M Tris-HCl at a pH of 6.8. The resulting lysates were boiled for 5 
minutes. Protein samples were separated by SDS-PAGE on 10% gels and transferred 
to PVDF membranes overnight at 30V. The membranes were then blocked with 5% 
non-fat dry milk in PBS containing 0.1% Tween-20 for 1 hour at room temperature 
and incubated with primary antibody at a concentration of 1:100 for 2 hours at room 
temperature. After the incubation with the primary antibody, the membranes were 
washed and incubated with secondary antibody at a concentration of 1:1000 for 1 
hour at room temperature. The membranes were then washed, and the bands 
visualized by treating the membranes with western blotting chemiluminescent 
reagent ECL (GE Healthcare). The results were obtained on an X-ray film (Agfa 
Healthcare). The levels of protein expression were compared by densitometry using 
the ImageJ software. 
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2.6. Immunostaining 
 
The cells were plated on cover slips, and the appropriate treatment was applied. 
Cells were fixed with 4% paraformaldehyde for 10 minutes, and permeabilized with 
0.5% Triton-X100 for 10 minutes. To decrease background fluorescence, cells were 
rinsed with 0.1 M glycine then incubated with 0.1 M glycine for 10 minutes. For 
blocking, cells were incubated 4 times with 1% BSA, 1% FBS in PBS for 5 minutes. 
Samples were stained with primary antibodies for 2 hours and with fluorophore-
conjugated secondary antibodies for 2 hours. Fluorescent images were taken using a 
60X objective on a fluorescent microscope. 
 
2.7. Motility assay 
 
For motility analysis, images of cells moving randomly in serum were 
collected every 60 seconds for 2 hours using a 20X objective. During imaging, the 
temperature was controlled using a Nikon heating stage which was set at 37 °C. The 
medium was buffered using HEPES and overlayed with mineral oil. The speed of 
cell movement was quantified using the ROI tracker plugin in the ImageJ software, 
which was used to calculate the total distance travelled by individual cells. The speed 
is then calculated by dividing this distance by the time (120 minutes) and reported in 
µm/min. The speed of at least 15 cells for each condition was calculated. The net 
distance travelled by the cell was calculated by measuring the distance travelled 
between the first and the last frames. 
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2.8. Pulldown assays 
 
Cells were lysed and incubated with GST-CRIB or GST-RBD and the 
pulldown assay performed using the RhoA/Rac1/Cdc42 Activation Assay Combo Kit 
(Cell BioLabs) following the manufacturer’s instructions. Lysates were incubated 
with GST-PAK (for Rac1/Cdc42) for 1 hour at 4 °C. GTP-Cdc42 was detected by 
western blotting using the anti-Cdc42 antibodies provided in the kit. Total proteins 
were collected prior to the incubation with GST beads and used as a loading control. 
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Chapter III 
?
Results 
 
3.1. Cdc42 protein depletion levels 
 
 In order to determine the role of Cdc42 in different cellular processes, the 
protein expression levels were depleted from SF268 cells by knocking down Cdc42 
by using two different oligos (oligo 4 & 7) each with different sequence. The results 
showed more depletion effectiveness when using siCdc42 oligo 4. Cdc42 expression 
levels decreased by approximately 14% when using oligo 7 while it decreased 
approximately 95% when using oligo 4. Thus, siCdc42 oligo 4 was used for further 
experimentation (Figure 9). 
 
 
 
Figure 9. Cdc42 expression levels in SF268 upon knock down. A. 
Western blot bands showing different expression levels of Cdc42 upon 
knock down. B. Western blot band quantification showing an effective 
depletion of Cdc42 expression when using oligo 4. (n=3) 
 21 
3.2. 2D cell motility is Cdc42 independent 
  
 After determining the most effective siCdc42 oligo, we wanted to test the role 
of Cdc42 in 2D cell motility in SF268. Astrocytoma cells were transfected with 
siCdc42 oligo 4 and then imagied. A control phenotype without the presence of a 
knock down was compared to the knock down phenotype. Control and knock down 
phenotypes showed approximately the same speed (Control (Luc): 0.0265 µm /min 
and knock down (KD): 0.0293 µm /min) (Figure 10). 
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Figure 10. 2D motility of SF268 is Cdc42 independent. Segment length 
quantification of time lapse movies for control (Luc) and knock down (KD) 
phenotypes was assessed using ImageJ. (n=10 cells). 
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3.3. PMA-mediated invadopodia induction in MTLn3 breast cancer 
cells and SF268 cells 
 
 MTLn3 breast cancer cells exhibited an invadopodia induction phenotype 
upon treatment with PMA for one hour. Compared to SF268 cells, MTLn3 cells 
showed more invadopodia and denser ones (Figure 11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control         PMA 
MTLn3 
SF268 
Figure 11. PMA-mediated invadopodia comparison between MTLn3 
and SF268 cells. PMA induced MTLn3 cells showed more and denser 
invadopodia than SF268 cells. 
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3.4. Arp2/3 and Cortactin co-localize at the invadopodia level in 
MTLn3 cells 
 
We wanted to test later on the credibility of the invadopodia present in PMA 
induced MTLn3 cells by detecting some of the major proteins present like Arp2/3 
and Cortactin. Immunostaining experiments showed that these structures are actin 
rich and are found to bind Arp2/3 and Cortactin (Figure 12). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5. PMA-mediated invadopodia are Cdc42 dependent in MTLn3 
and SF268 cells 
 
After making sure of the invadopodia’s nature, we wanted to determine the role 
of Cdc42 in invadopodia formation in both MTLn3 and SF268 cells. Knock down 
and immunostaining results showed that invadopodia formation is dependent on 
Cdc42 (Figure 13). 
Control   PMA 
Figure 12. PMA-mediated invadopodia are of actin 
nature and co-localize Cortactin and Arp2/3. The 
control phenotype did not show any invadopodia 
formation. PMA stimulated MTLn3 cells showed 
invadopodia formation. Actin was stained with 
Rhodamine-Phalloidin (red), Cortactin and Arp2/3 were 
stained with green and blue, respectively. 
 24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control       PMA 
Luciferase 
Cdc42 KD 
A 
Control          PMA 
Luciferase 
Cdc42 KD 
B 
Figure 13. Invadopodia formation in MTLn3 and SF268 cells is 
Cdc42 dependent. A. Invadopodia formation comparison between 
control MTLn3 cells and induced ones after different knock downs 
(Luciferase and Cdc42). Actin was stained with Rhodamine-
Phalloidine (red), Cortactin in green and Arp2/3 in blue. B. 
Invadopodia formation comparison between control SF268 and 
induced ones after different knock downs (Luciferase and Cdc42).  
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3.6. Crosstalk between RhoA and Cdc42 in SF268 cells 
 
It was shown that RhoA and RhoC are involved in focal adhesions and 
invadopodia formation, respectively. Since invadopodia formation is Cdc42 
dependent, we wanted to determine any crosstalk present between RhoA, RhoC and 
Cdc42.  The activation levels of Cdc42 were assessed by pull down assay after RhoA 
knock down. Upon RhoA depletion, Cdc42 activation levels decrease. Thus, RhoA 
upregulates Cdc42 activation levels (Figure 14). 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. RhoA upregulates Cdc42 activation levels in SF268. A. RhoA knock 
down efficiency; western blot bands showing the decreased level of RhoA protein 
expression and a quantification graph of the western blot band showing an 87% 
decrease in RhoA protein expression (n=3). B. Western blot bands showing the 
decreased activation levels of Cdc42 (active Cdc42) compared to total Cdc42 upon 
RhoA knock down and a quantification graph of the western blot bands showing a 
decrease in Cdc42 activation levels by 29.5% upon RhoA knock down.  
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3.7.Crosstalk between RhoC and Cdc42 in SF268 cells 
 
 After elucidating a crosstalk between RhoA and Cdc42, it was interesting to 
assess another one between RhoC and Cdc42 since RhoC is known to be involved 
also in invadopodia formation. Pull down assays showed that upon RhoC knock 
down, Cdc42 activation levels increase. Thus, RhoC downregulates Cdc42 activation 
levels in SF268 cells (Figure 15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. RhoC downregulates Cdc42 activation levels in SF268. A. RhoC knock 
down efficiency; western blot bands showing the decreased level of RhoC protein 
expression and a quantification graph of the western blot band showing a 93% 
decrease in RhoC protein expression (n=3). B. Western blot bands showing the 
increased activation levels of Cdc42 (active Cdc42) compared to total Cdc42 upon 
RhoC knock down and a quantification graph of the western blot bands showing an 
increase in Cdc42 activation levels by 33.8% upon RhoC knock down.  
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3.8. Crosstalk between Palladin and Cdc42 in SF268 cells 
 
 Palladin was shown to be involved in the invasive profile of CAFs, thus it is 
interesting to study any potential signaling pathway between Palladin and Cdc42 in 
SF268 cells. Pull down assays revealed that upon Palladin knock down, Cdc42 
activation levels increase hence Palladin downregulates Cdc42 activation levels in 
SF268 cells (Figure 16) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
B 
Figure 16. Palladin downregulates Cdc42 activation levels in SF268. A. 
Palladin knock down efficiency; western blot bands showing the decreased 
level of Palladin protein expression and a quantification graph of the 
western blot band showing a 98.3% decrease in Palladin protein expression. 
(n=3) B. Western blot bands showing the increased activation levels of 
Cdc42 (active Cdc42) compared to total Cdc42 upon Palladin knock down 
and a quantification graph of the western blot bands showing an increase in 
Cdc42 activation levels by 72.8% upon Palladin knock down.   
A 
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Chapter IV 
?
Discussion 
 
Previous studies state the role of many Rho GTPases and their regulators in 
cell motility. Khalil, et al., (2014) reported the role of RhoA and StarD13, a GAP, in 
astrocytoma cell migration by modeling focal adhesions. The knockdown of StarD13 
inhibited cellular migration through inhibition of RhoA (Khalil, Hanna, Saykali, 
Nasrallah, Marston, ... & El-Sibai, 2014). The same phenotype was observed in 
colorectal cancer cells (Nasrallah, Saykali, Al Dimassi, Khoury, Hanna, & El-Sibai, 
2014) and in breast cancer cells (Hanna, Khalil, Nasrallah, Saykali, Sobh, Nasser, & 
El-Sibai, 2014). In addition, the role of Cdc42 in EGF-stimulated protrusion and 
motility in MTLn3 carcinoma cells was assessed by El Sibai et al., (2007). And since 
it was shown involved in PMA-induced invadopodia assembly in smooth muscle 
cells, metastatic rat carcinoma mammary cells, and human melanoma cells 
(Goicoechea, et al., 2008), it was interesting to elucidate its role in cellular motility 
and in invadopodia formation in MTLn3 and SF268 cells as well as its signaling 
relationship with RhoA, RhoC and Palladin.   
 
 Surprisingly, 2D motility of astrocytoma cells was shown to be independent 
of Cdc42. The silencing of Cdc42 in SF268 cells (Figure 9) did not affect their 2D 
motility (Figure 10). Both phenotypes exhibited the same average speed per cell 
(Control (Luc): 0.0265 µm/min and KD: 0.0293 µm /min). This contradicts a study 
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done by El Sibai et al., (2007) where it was shown that Cdc42 is actually involved in 
the motility of MTLn3 carcinoma cells upon EGF stimulation. 
 
 In the literature, the effect of Cdc42 on invadopodia and the invasiveness of 
cancer cells were described by Keely, et al. (1997) and Goicoechea, et al., (2008). 
This effect was assessed in this study in MTLn3 and SF268 cells and our results 
showed that invadopodia formation is completely dependent on the presence of 
Cdc42. The depletion of Cdc42 from PMA induced cells inhibited the formation of 
invadopodia (Figures 11 & 13). In order to verify the nature of the newly formed 
invadopodia, PMA induced MTLn3 cells were fixed and stained for Cortactin and 
Arp2/3, key characteristics for the formation of invadopodia, as well as for actin. 
Immunostaining results showed the co-localization of these two proteins at the 
invadopodia level, which determines the molecular nature of these invasive 
structures (Figure 12).  
 
Usually, invadopodia are RhoC driven by restricting the activity of Cofilin to 
the invadopodia core only (Bravo-Cordero, et al., 2011; MacGrath,  & Koleske, 
2011). In addition, since Cdc42 was shown to be involved in invadopodia formation, 
we looked for any possible crosstalk between RhoA, RhoC and Cdc42. Our results 
exposed a crosstalk between RhoA and Cdc42. The activation levels of Cdc42 were 
upregulated by RhoA (Figure 14). One possible explanation can be the involvement 
of RhoA in regulating Cdc42 in order to form invadopodia. Maybe the dissolution of 
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the RhoA driven focal adhesions and the formation of invadopodia (Figure 4) (Chan, 
Cortesio, & Huttenlocher, 2009) constitute a plausible explanation of this crosstalk 
and thus regulating the quiescent phenotype of cancer cells to become motile in 3D.  
 
Concerning the relationship between RhoC and Cdc42, we showed that RhoC 
downregulates Cdc42 activation levels by pull down assays (Figure 15). This is the 
first time that any possible relationship was assessed between RhoC and Cdc42. This 
downregulation of Cdc42 leading to a decrease in invadopodia formation can explain 
a recent work in our lab, which states that RhoC knock down induces an increase in 
SF268 invasiveness (Figure 17).  
 
After uncovering the relationship between different Rho GTPases in 
invadopodia formation in SF268 cells, it is intriguing to study the role of Palladin in 
this process since it was shown by Goicoechea, et al. (2013) to be not only involved 
in cell adhesion and motility, but also in invasive motility of cancer invasive cells 
more specifically in CAFs. According to the present results, Palladin downregulates 
Cdc42 activation levels (Figure 16), thus demonstrating its role in the invasiveness 
profile of another cancer cell line. A proposed model (Figure 17) summarizes all our 
findings and questions additional possible crosstalks between Palladin and Rho 
GTPases.  
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Figure 17. Proposed signaling pathway model of invadopodia formation in SF268 
cells. Palladin and RhoC downregulates Cdc42 and RhoA upregulates it. RhoC and 
Cdc42 are involved in invadopodia formation but ROCK inhibit their formation. 
Unknown pathways between Palladin and Rho GTPases are yet to be uncovered. 
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Chapter V 
?
Conclusion 
 
 This study aimed to determine the role of Cdc42 in different cellular 
processes. We examined the role of Cdc42 in 2D cell motility of SF268 cells and to 
our surprise, it showed to be independent in contrary to MTLn3 cells. Our results 
also showed the invadopodia formation dependence on Cdc42 in both MTLn3 and 
SF268 cells and the molecular nature of the newly formed invadopodia (co-
localization of Cortactin and Arp2/3). In addition, a crosstalk between the three 
members of Rho GTPases was uncovered, regulating invadopodia formation. RhoA 
and RhoC knock down revealed an increase and decrease in Cdc42 activation levels, 
respectively. A crosstalk between Palladin and Cdc42 was also revealed where 
Palladin knock down increased Cdc42 activation levels. 
 Future work involves the discovery of potential signaling relationships 
between Palladin and the members of Rho GTPases and between Cdc42 and ROCK. 
In addition, overexpression of Cdc42 will be done in order to verify its role in 
invadopodia formation. Furthermore, FRET studies will be conducted in a purpose to 
study spatiotemporal localization of Cdc42 in SF268 cells. Finally, in-vivo studies 
will determine the role of Cdc42 on invadopodia formation in mice. 
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